KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Inventory Average: 2019-2025

Historic Inventory Average for Adaptive Biotechnologies (ADPT) over the last 6 years, with Sep 2025 value amounting to $9.2 million.

  • Adaptive Biotechnologies' Inventory Average fell 27.15% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year decrease of 27.15%. This contributed to the annual value of $11.4 million for FY2024, which is 20.81% down from last year.
  • Per Adaptive Biotechnologies' latest filing, its Inventory Average stood at $9.2 million for Q3 2025, which was up 7.31% from $8.5 million recorded in Q2 2025.
  • Adaptive Biotechnologies' 5-year Inventory Average high stood at $20.1 million for Q1 2022, and its period low was $8.5 million during Q2 2025.
  • Its 3-year average for Inventory Average is $13.5 million, with a median of $13.3 million in 2024.
  • Its Inventory Average has fluctuated over the past 5 years, first skyrocketed by 73.20% in 2021, then tumbled by 39.91% in 2024.
  • Over the past 5 years, Adaptive Biotechnologies' Inventory Average (Quarterly) stood at $18.7 million in 2021, then decreased by 15.19% to $15.9 million in 2022, then rose by 6.73% to $17.0 million in 2023, then tumbled by 39.91% to $10.2 million in 2024, then dropped by 27.15% to $9.2 million in 2025.
  • Its Inventory Average stands at $9.2 million for Q3 2025, versus $8.5 million for Q2 2025 and $8.6 million for Q1 2025.